Impact of Combined Low-Level Mupirocin and Genotypic Chlorhexidine Resistance on Persistent Methicillin-Resistant Staphylococcus aureus Carriage After Decolonization Therapy: A Case-control Study
Author(s) -
Andie S. Lee,
Marina Macedo-Viñas,
Patrice François,
Gesuèle Renzi,
Jacques Schrenzel,
Nathalie Vernaz,
Didier Pittet,
Stephan Harbarth
Publication year - 2011
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cir233
Subject(s) - mupirocin , medicine , carriage , methicillin resistant staphylococcus aureus , chlorhexidine , staphylococcus aureus , microbiology and biotechnology , dentistry , pathology , biology , bacteria , genetics
The clinical importance of low-level mupirocin resistance and genotypic chlorhexidine resistance remains unclear. We aimed to determine whether resistance to these agents increases the risk of persistent methicillin-resistant Staphylococcus aureus (MRSA) carriage after their use for topical decolonization therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom